Predictive and prognostic markers in colorectal cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Colorectal cancer (CRC) pathogenesis involves sequential genetic and epigenetic alterations.
• CRC treatment has evolved significantly with advances in understanding disease biology and targeted therapies.
• Personalized medicine necessitates identifying molecular pathways and therapeutic targets in CRC.

Purpose of the Study:

• To review prognostic and predictive biomarkers for colorectal cancer.
• To highlight markers with substantial evidence for clinical utility.
• To explore the connection between CRC pathogenesis and potential biomarkers.

Main Methods:

• Literature review focusing on prognostic and predictive markers in colorectal cancer.
• Analysis of existing data supporting the role of biomarkers in clinical practice.
• Synthesis of information on molecular pathways and genetic alterations in CRC.

Main Results:

• Identification of key biomarkers linked to CRC prognosis and treatment prediction.
• Evaluation of the evidence base for the clinical application of these markers.
• Discussion of the role of biomarkers in the context of personalized medicine for CRC.

Conclusions:

• Prognostic and predictive biomarkers are crucial for advancing colorectal cancer care.
• Markers intimately connected to CRC pathogenesis hold significant clinical potential.
• Further research and validation are essential for integrating biomarkers into routine CRC practice.